Mini Review

Published on 20 Dec 2017

The Amide Local Anesthetic Lidocaine in Cancer Surgery—Potential Antimetastatic Effects and Preservation of Immune Cell Function? A Narrative Review

in Regulatory Science

Thiên-Nga Chamaraux-Tran
Tobias Piegeler

Frontiers in Medicine

doi 10.3389/fmed.2017.00235

12,512 views
64 citations

Mini Review

Published on 07 Dec 2017

Innovative Approaches to Increase Access to Medicines in Developing Countries

in Regulatory Science

Hilde Stevens
Isabelle Huys

Frontiers in Medicine

doi 10.3389/fmed.2017.00218

58,196 views
62 citations

Review

Published on 29 Nov 2017

Drug Repurposing for the Treatment of Acute Myeloid Leukemia

in Regulatory Science

Vibeke Andresen
Bjørn T. Gjertsen

Frontiers in Medicine

doi 10.3389/fmed.2017.00211

17,371 views
28 citations

Review

Published on 26 Oct 2017

Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework

in Regulatory Science

Marta Carvalho
Bruno Sepodes
Ana Paula Martins

Frontiers in Medicine

doi 10.3389/fmed.2017.00182

31,595 views
49 citations

Original Research

Published on 25 Aug 2017

Collaborative Approaches and Policy Opportunities for Accelerated Progress toward Effective Disease Prevention, Care, and Control: Using the Case of Poverty Diseases to Explore Universal Access to Affordable Health Care

in Regulatory Science

Samia Laokri

Frontiers in Medicine

doi 10.3389/fmed.2017.00130

4,520 views
4 citations

Review

Published on 16 Aug 2017

More Haste, Less Speed: Could Public–Private Partnerships Advance Cellular Immunotherapies?

in Regulatory Science

Tania Bubela
Katherine Bonter
Silvy Lachance
Jean-Sébastien Delisle
E. Richard Gold

Frontiers in Medicine

doi 10.3389/fmed.2017.00134

5,938 views
8 citations

Perspective

Published on 21 Jul 2017

Data Management in a Regulatory Context

in Regulatory Science

Niels Grønning

Frontiers in Medicine

doi 10.3389/fmed.2017.00114

8,198 views
11 citations

Mini Review

Published on 16 Jun 2017

Postgraduate Courses in Pharmaceutical Medicine in Italy

in Regulatory Science

Domenico Criscuolo

Frontiers in Medicine

doi 10.3389/fmed.2017.00079

4,856 views
2 citations

Review

Published on 12 Jun 2017

Advancing Public Health Using Regulatory Science to Enhance Development and Regulation of Medical Products: Food and Drug Administration Research at the Center for Biologics Evaluation and Research

in Regulatory Science

Marc Kusinitz
Emily Braunstein
Carolyn A. Wilson

Frontiers in Medicine

doi 10.3389/fmed.2017.00071

5,319 views
5 citations

Review

Published on 29 May 2017

Adaptation through Collaboration: Developing Novel Platforms to Advance the Delivery of Advanced Therapies to Patients

in Regulatory Science

Magdalini Papadaki

Frontiers in Medicine

doi 10.3389/fmed.2017.00056

7,198 views
14 citations

Original Research

Published on 16 May 2017

Advanced Therapy Medicinal Products for Rare Diseases: State of Play of Incentives Supporting Development in Europe

in Regulatory Science

Andreas M. Farkas
Segundo Mariz
Violeta Stoyanova-Beninska
Patrick Celis
Spiros Vamvakas
Kristina Larsson
Bruno Sepodes

Frontiers in Medicine

doi 10.3389/fmed.2017.00053

10,287 views
26 citations

Review

Published on 20 Jan 2017

Public–Private Partnerships in Cloud-Computing Services in the Context of Genomic Research

in Regulatory Science

Palmira Granados Moreno
Yann Joly
Bartha Maria Knoppers

Frontiers in Medicine

doi 10.3389/fmed.2017.00003

11,758 views
18 citations

Mini Review

Published on 19 Jan 2017

The European Lead Factory: A Blueprint for Public–Private Partnerships in Early Drug Discovery

in Regulatory Science

Anna Karawajczyk
Kristina M. Orrling
Jon S. B. de Vlieger
Ton Rijnders
Dimitrios Tzalis

Frontiers in Medicine

doi 10.3389/fmed.2016.00075

6,959 views
29 citations

Perspective

Published on 14 Nov 2016

Challenges for Relative Effectiveness Assessment and Early Access of Cancer Immunotherapies in Europe

in Regulatory Science

Mira Pavlovic

Frontiers in Medicine

doi 10.3389/fmed.2016.00056

3,245 views
3 citations

Review

Published on 14 Oct 2016

Prediction of the Carcinogenic Potential of Human Pharmaceuticals Using Repeated Dose Toxicity Data and Their Pharmacological Properties

in Regulatory Science

Jan Willem van der Laan
Wenny H. W. Buitenhuis
Laura Wagenaar
Ans E. M. F. Soffers
Eugene P. van Someren
Cyrille A. M. Krul
Ruud A. Woutersen

Frontiers in Medicine

doi 10.3389/fmed.2016.00045

7,491 views
25 citations

Technology Report

Published on 12 Oct 2016

Distributed Cognition and Process Management Enabling Individualized Translational Research: The NIH Undiagnosed Diseases Program Experience

in Regulatory Science

Amanda E. Links
David Draper
Elizabeth Lee
Jessica Guzman
Zaheer Valivullah
Valerie Maduro
Vlad Lebedev
Maxim Didenko
Garrick Tomlin
Michael Brudno

Frontiers in Medicine

doi 10.3389/fmed.2016.00039

3,841 views
2 citations

Navigation group

Articles

The Amide Local Anesthetic Lidocaine in Cancer Surgery—Potential Antimetastatic Effects and Preservation of Immune Cell Function? A Narrative Review

Innovative Approaches to Increase Access to Medicines in Developing Countries

Drug Repurposing for the Treatment of Acute Myeloid Leukemia

Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework

Collaborative Approaches and Policy Opportunities for Accelerated Progress toward Effective Disease Prevention, Care, and Control: Using the Case of Poverty Diseases to Explore Universal Access to Affordable Health Care

More Haste, Less Speed: Could Public–Private Partnerships Advance Cellular Immunotherapies?

Data Management in a Regulatory Context

Postgraduate Courses in Pharmaceutical Medicine in Italy

Advancing Public Health Using Regulatory Science to Enhance Development and Regulation of Medical Products: Food and Drug Administration Research at the Center for Biologics Evaluation and Research

Adaptation through Collaboration: Developing Novel Platforms to Advance the Delivery of Advanced Therapies to Patients

Advanced Therapy Medicinal Products for Rare Diseases: State of Play of Incentives Supporting Development in Europe

Public–Private Partnerships in Cloud-Computing Services in the Context of Genomic Research

The European Lead Factory: A Blueprint for Public–Private Partnerships in Early Drug Discovery

Challenges for Relative Effectiveness Assessment and Early Access of Cancer Immunotherapies in Europe

Prediction of the Carcinogenic Potential of Human Pharmaceuticals Using Repeated Dose Toxicity Data and Their Pharmacological Properties

Distributed Cognition and Process Management Enabling Individualized Translational Research: The NIH Undiagnosed Diseases Program Experience